Osteoporosis in Africa—where are we now

被引:0
|
作者
F. Paruk
M. Tsabasvi
A. A. Kalla
机构
[1] University of KwaZulu-Natal,Department of Rheumatology, Inkosi Albert Luthuli Central Hospital, School of Clinical Medicine, College of Health Science
[2] Harare Central Hospital,Department of Surgery
[3] University of Cape Town,Orthopaedics and Traumatology
来源
Clinical Rheumatology | 2021年 / 40卷
关键词
Africa; Hip fracture; Incidence rates; Osteoporosis;
D O I
暂无
中图分类号
学科分类号
摘要
Africa is experiencing an exponential increase in the number of older persons. The number of persons surviving with human immunodeficiency virus is simultaneously increasing due to improved availability of anti-retroviral therapy. The burden of non-communicable diseases, in particular, osteoporosis and its consequent fragility fractures, is also predicted to increase. Osteoporosis, however, remains a neglected disease and there are no age-standardized reference data available to accurately screen and diagnose individuals with osteoporosis. Epidemiological studies reporting the incidence of hip fracture or vertebral fractures are limited from Africa, especially Sub-Saharan Africa. The studies are usually limited as they are based on a retrospective data and small study numbers and often from a single study site. However, compared with early initial studies, the more recent studies show that osteoporosis and fractures are increasing across the continent. The overall incidence rates for osteoporosis and fractures still vary greatly between different regions in Africa and ethnic groups. Predisposing factors are similar with those in developed countries, but awareness of osteoporosis is sorely lacking. There is a lack of awareness among the population as well as health authorities, making it extremely difficult to quantify the burden of disease. There is great potential for research into the need and availability of preventive strategies. The FRAX® tool needs to be developed for African populations and may circumvent the shortage of bone densitometry.
引用
收藏
页码:3419 / 3428
页数:9
相关论文
共 50 条
  • [21] Secondary Prevention of Osteoporosis: If Not Now, When?
    Dwolatzky, Tzvi
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2022, 13 (03):
  • [22] Plain vitamin D or active vitamin D in the treatment of osteoporosis: where do we stand today?
    Johann Diederich Ringe
    Archives of Osteoporosis, 2020, 15
  • [23] Plain vitamin D or active vitamin D in the treatment of osteoporosis: where do we stand today?
    Ringe, Johann Diederich
    ARCHIVES OF OSTEOPOROSIS, 2020, 15 (01)
  • [24] Personalized fracture risk assessment: where are we at?
    Nguyen, Tuan V.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2021, 16 (04) : 191 - 200
  • [25] Osteosarcopenia: where osteoporosis and sarcopenia collide
    Clynes, Michael A.
    Gregson, Celia L.
    Bruyere, Olivier
    Cooper, Cyrus
    Dennison, Elaine M.
    RHEUMATOLOGY, 2021, 60 (02) : 529 - 537
  • [26] Sustainable ICT4D in Africa: Where Do We Go from Here?
    Bissyande, Tegawende F.
    Ahmat, Daouda
    Ouoba, Jonathan
    van Stam, Gertjan
    Klein, Jacques
    Le Traon, Yves
    E-INFRASTRUCTURE AND E-SERVICES FOR DEVELOPING COUNTRIES, AFRICOMM 2013, 2014, 135 : 95 - +
  • [27] Ecohealth research in Africa: Where from-Where to?
    Bergquist, Robert
    Brattig, Norbert W.
    Chimbari, Moses J.
    Zinsstag, Jakob
    Utzinger, Jurg
    ACTA TROPICA, 2017, 175 : 1 - 8
  • [28] Turner Syndrome where are we?
    Khan, Najma
    Farooqui, Anam
    Ishrat, Romana
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [29] Why we are not all multiregionalists now
    Stringer, Chris
    TRENDS IN ECOLOGY & EVOLUTION, 2014, 29 (05) : 248 - 251
  • [30] The aftermath of hip fragility fractures are we missing out on osteoporosis treatment?
    Costa, R.
    Romano, J.
    Moreira, A.
    Dantas, D.
    Ribeiro, P.
    Agre, M.
    Correia, J.
    ACTA REUMATOLOGICA PORTUGUESA, 2021, 46 (04): : 328 - 332